HealthStream (NASDAQ:HSTM - Get Free Report)'s stock had its "hold (c)" rating reaffirmed by stock analysts at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.
Separately, Canaccord Genuity Group reduced their price objective on shares of HealthStream from $29.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $31.00.
Get Our Latest Report on HSTM
HealthStream Price Performance
HealthStream stock opened at $27.18 on Wednesday. The stock has a market cap of $805.64 million, a P/E ratio of 40.57, a PEG ratio of 3.37 and a beta of 0.47. HealthStream has a 1 year low of $25.36 and a 1 year high of $34.24. The firm's 50 day moving average price is $27.67 and its 200-day moving average price is $28.64.
HealthStream (NASDAQ:HSTM - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The technology company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.02. The firm had revenue of $74.40 million for the quarter, compared to analysts' expectations of $74.39 million. HealthStream had a net margin of 6.89% and a return on equity of 5.70%. HealthStream has set its FY 2025 guidance at EPS. As a group, equities analysts expect that HealthStream will post 0.63 EPS for the current year.
Insider Buying and Selling at HealthStream
In related news, EVP Kevin P. O'hara sold 2,000 shares of the firm's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $27.97, for a total value of $55,940.00. Following the completion of the transaction, the executive vice president directly owned 17,137 shares of the company's stock, valued at approximately $479,321.89. This trade represents a 10.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 20.50% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. GAMMA Investing LLC grew its holdings in shares of HealthStream by 30.8% in the first quarter. GAMMA Investing LLC now owns 2,082 shares of the technology company's stock valued at $67,000 after purchasing an additional 490 shares in the last quarter. SG Americas Securities LLC lifted its position in HealthStream by 9.3% in the first quarter. SG Americas Securities LLC now owns 18,648 shares of the technology company's stock worth $600,000 after buying an additional 1,584 shares during the last quarter. Principal Financial Group Inc. lifted its position in HealthStream by 2.5% in the first quarter. Principal Financial Group Inc. now owns 129,830 shares of the technology company's stock worth $4,178,000 after buying an additional 3,157 shares during the last quarter. Nuveen LLC bought a new stake in HealthStream in the first quarter worth $2,380,000. Finally, Envestnet Asset Management Inc. lifted its position in HealthStream by 186.3% in the first quarter. Envestnet Asset Management Inc. now owns 125,457 shares of the technology company's stock worth $4,037,000 after buying an additional 81,644 shares during the last quarter. 69.58% of the stock is owned by hedge funds and other institutional investors.
About HealthStream
(
Get Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.